Translational Research Cancer Centers Consortium

Translational Research Cancer Centers Consortium

Expediting Progress in Cancer Immunotherapy
Wednesday, February 14
2 pm Registration and Poster Set-Up
3 pm  Welcome Address 

Dr. Laura Gibson, PhD
Senior Associate Vice President for Research & Graduate Education, Deputy Director
WVU Cancer Institute

3:15 pm

Introduction of Keynote Speaker
Moderator: Dr. David J. Klinke, PhD


Opening Keynote Lecture 
Robert L. Ferris, MD, PhD
Hillman Professor of Oncology
Director, UPMC Hillman Cancer Center
Co-Director, Tumor Microenvironment Center
Associate Vice-Chancellor for Cancer Research
Professor of Otolaryngology, Immunology, and Radiation Oncology, University of Pittsburgh School of Medicine

4:15 Break

Symposium 1 : Strategies to ignite productive T cell immunity in Cancer

Chairs: Drs. Dan Powell and Todd Schell

4:30 pm

Targeting immunosuppression in breast cancer
Robert Wesolowski, MD, Ohio State University


Immune responses after radiation
Jason Muhitch, PhD, Roswell Park Cancer Institute


STING agonist in breast cancer
Leisha A. Emens, MD, PhD, Johns Hopkins University


Imaging Response to Cancer Immunotherapy
Nerissa Viola-Villegas, PhD, Karmanos Cancer Institute


Abstract Presentations


Sponsor Presentation

6:30 pm 

Welcome Reception – meet with delegates, browse posters and sponsor exhibits

Stage 1 of sponsor scavenger hunt

Thursday, February 15

7 am Breakfast
8:30 am

Concurrent Trainee Sessions 1 & 2

Session 1 Chairs : Drs. Wei-Zen Wei and David Bartlett

Session 2 Chairs : Drs. Elizabeth Repasky and Tullia Bruno

9:45 am

Browse posters and sponsor exhibits

Stage 2 of sponsor scavenger hunt

Symposium 2 – Targeting Metabolism in Cancer

Chairs: Drs. Marc Ernstoff and David Linehan

10 am

Metabolic changes in tumor cells as a therapeutic target
Subhamoy Dasgupta, PhD, Roswell Park Cancer Institute


Variance in T cell metabolic status in cancer patients: It's what's on the inside that counts
David M. Barrett, MD PhD, University of Pennsylvania


Systems Approaches for dissecting metabolic influences of the tumor microenvironment
Deepak Nagrath, PhD, University of Michigan


Additional Speakers – TBA


Abstract Presentations


Sponsor Presentation

12:30 pm

Advocate Networking Lunch 
Patient advocates will be available for one-on-one discussions with delegates

1:30 pm

Concurrent Trainee Sessions 3 & 4

Session 3 Chairs : Drs. Joseph Baar and Jason Muhitch

Session 4 Chairs : Drs. John Frelinger and Connie Jo Rogers

2:45 pm


Symposium 3 – Cancer Therapeutics

3 pm

Molecular markers of immune checkpoint response
Peter A. Prieto, MD, University of Rochester


Immunotherapies in lung cancer
Patrick Ma, MD, West Virginia University


Designing Self-Assembled Peptide Nanotherapeutics for Precision Medicine
Scott Medina, PhD, Penn State University


Microbiome interactions with immune checkpoint blockade
Diwakar Davar, PhD, University of Pittsburgh


Additional Speakers TBA


Abstract Presentations


Sponsor Presentation 

5 pm 

Networking session
Browse posters and sponsor exhibits
Final stage of sponsor scavenger hunt

6 pm

Dinner stations and formal poster presentation

Presenters of posters 1 -30 should be available at their posters from 6:00 -6:45 pm
Presenters of posters 31 -60 should be available at their posters from 6:45 - 7:30 pm

Friday, February 16

7 am Breakfast
8: 30 am

Concurrent Trainee Sessions 5 & 6

Session 5 Chairs : Drs. Dario Vignali and Scott Gerber

Session 6 Chairs : Drs. Kelvin Lee and Tom Mace

9:45 am Break and Room Check-out 
10:15 am

Meet the patient session/Immunotherapy Rounds: Translating between Lab and Clinic
Patients receiving immunotherapy will discuss the therapy and outcomes along with their attending physicians and the audience


Richard Goldberg, M.D. West Virginia University

Symposium 4 – Targeting the Tumor Microenvironment
11 am

Targeting clonal heterogeneity in treatment-refractory glioblastoma with novel and empiric immunotherapies
Sheila Singh, MD PhD, McMaster University


Antigen garnish: ensemble neoepitope prediction from DNA variants
Andrew J. Rech, PhD, University of Pennsylvania


High-dimensional characterization of the TIL landscape
Arnold Han, MD PhD, Columbia University


Additional Speakers - TBA

12:30 pm Lunch
1:30 pm

Introduction of Keynote Speaker
Moderator: Dr. Pawel Kalinski, MD, PhD


Closing Keynote Lecture
Dr. Pamela S. Ohashi, Ph.D.
Professor, Department of Immunology and Medical Biophysics, University of Toronto;
Director, Immune Therapy Program, Ontario Cancer Institute
Co-Director, Campbell Family Institute for Breast Cancer Research
Senior Scientist, Ontario Cancer Institute/Princess Margaret Cancer Centre, University Health Network
Canada Research Chair in Autoimmunity and Tumour Immunity

2:30 pm

Presentation of trainee awards

Closing Remarks – Richard Goldberg, David Klinke – West Virginia University


Meeting Adjournment


Take down posters

2018 Annual Meeting Program Agenda